Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Getting new auth cookie, if you see this message a lot, tell someone!
Research ArticleAdult Brain

The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated MGMT Promoter

Y.S. Choi, S.S. Ahn, H.-J. Lee, J.H. Chang, S.-G. Kang, E.H. Kim, S.H. Kim and S.-K. Lee
American Journal of Neuroradiology August 2017, 38 (8) 1528-1535; DOI: https://doi.org/10.3174/ajnr.A5265
Y.S. Choi
aFrom the Department of Radiology and Research Institute of Radiological Science (Y.S.C., S.S.A., H.-J.L., S.-K.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Y.S. Choi
S.S. Ahn
aFrom the Department of Radiology and Research Institute of Radiological Science (Y.S.C., S.S.A., H.-J.L., S.-K.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S.S. Ahn
H.-J. Lee
aFrom the Department of Radiology and Research Institute of Radiological Science (Y.S.C., S.S.A., H.-J.L., S.-K.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for H.-J. Lee
J.H. Chang
cNeurosurgery (J.H.C., S.-G.K., E.H.K.), Yonsei University College of Medicine, Seoul, Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J.H. Chang
S.-G. Kang
cNeurosurgery (J.H.C., S.-G.K., E.H.K.), Yonsei University College of Medicine, Seoul, Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S.-G. Kang
E.H. Kim
cNeurosurgery (J.H.C., S.-G.K., E.H.K.), Yonsei University College of Medicine, Seoul, Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E.H. Kim
S.H. Kim
bDepartments of Pathology (S.H.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S.H. Kim
S.-K. Lee
aFrom the Department of Radiology and Research Institute of Radiological Science (Y.S.C., S.S.A., H.-J.L., S.-K.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S.-K. Lee
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

REFERENCES

  1. 1.↵
    1. Stupp R,
    2. Mason WP,
    3. van den Bent MJ, et al
    ; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–96 doi:10.1056/NEJMoa043330 pmid:15758009
    CrossRefPubMedWeb of Science
  2. 2.↵
    1. Wangaryattawanich P,
    2. Hatami M,
    3. Wang J, et al
    . Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol 2015;17:1525–37 doi:10.1093/neuonc/nov117 pmid:26203066
    CrossRefPubMed
  3. 3.↵
    1. Pope WB,
    2. Sayre J,
    3. Perlina A, et al
    . MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 2005;26:2466–74 pmid:16286386
    Abstract/FREE Full Text
  4. 4.↵
    1. Choi YS,
    2. Ahn SS,
    3. Kim DW, et al
    . Incremental prognostic value of ADC histogram analysis over MGMT promoter methylation status in patients with glioblastoma. Radiology 2016;281:175–84
  5. 5.↵
    1. Hegi ME,
    2. Diserens AC,
    3. Godard S, et al
    . Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 2004;10:1871–74 doi:10.1158/1078-0432.CCR-03-0384 pmid:15041700
    Abstract/FREE Full Text
  6. 6.↵
    1. Law M,
    2. Young RJ,
    3. Babb JS, et al
    . Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247:490–98 doi:10.1148/radiol.2472070898 pmid:18349315
    CrossRefPubMedWeb of Science
  7. 7.↵
    1. Nguyen TB,
    2. Cron GO,
    3. Mercier JF, et al
    . Preoperative prognostic value of dynamic contrast-enhanced MRI-derived contrast transfer coefficient and plasma volume in patients with cerebral gliomas. AJNR Am J Neuroradiol 2015;36:63–69 doi:10.3174/ajnr.A4006 pmid:24948500
    Abstract/FREE Full Text
  8. 8.↵
    1. Choi YS,
    2. Kim DW,
    3. Lee SK, et al
    . The added prognostic value of preoperative dynamic contrast-enhanced MRI histogram analysis in patients with glioblastoma: analysis of overall and progression-free survival. AJNR Am J Neuroradiol 2015;36:2235–41 doi:10.3174/ajnr.A4449 pmid:26338911
    Abstract/FREE Full Text
  9. 9.↵
    1. Cheng HL
    . Improved correlation to quantitative DCE-MRI pharmacokinetic parameters using a modified initial area under the uptake curve (mIAUC) approach. J Magn Reson Imaging 2009;30:864–72 doi:10.1002/jmri.21916 pmid:19787732
    CrossRefPubMed
  10. 10.↵
    1. Chung WJ,
    2. Kim HS,
    3. Kim N, et al
    . Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging. Radiology 2013;269:561–68 doi:10.1148/radiol.13130016 pmid:23878286
    CrossRefPubMed
  11. 11.↵
    1. Hamilton JD,
    2. Lin J,
    3. Ison C, et al
    . Dynamic contrast-enhanced perfusion processing for neuroradiologists: model-dependent analysis may not be necessary for determining recurrent high-grade glioma versus treatment effect. AJNR Am J Neuroradiol 2015;36:686–93 doi:10.3174/ajnr.A4190 pmid:25500312
    Abstract/FREE Full Text
  12. 12.↵
    1. Prah MA,
    2. Stufflebeam SM,
    3. Paulson ES, et al
    . Repeatability of standardized and normalized relative CBV in patients with newly diagnosed glioblastoma. AJNR Am J Neuroradiol 2015;36:1654–61 doi:10.3174/ajnr.A4374 pmid:26066626
    Abstract/FREE Full Text
  13. 13.↵
    1. Paulson ES,
    2. Schmainda KM
    . Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008;249:601–13 doi:10.1148/radiol.2492071659 pmid:18780827
    CrossRefPubMedWeb of Science
  14. 14.↵
    1. Narang J,
    2. Jain R,
    3. Arbab AS, et al
    . Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro Oncol 2011;13:1037–46 doi:10.1093/neuonc/nor075 pmid:21803763
    CrossRefPubMed
  15. 15.↵
    1. Walker-Samuel S,
    2. Leach MO,
    3. Collins DJ
    . Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis. Phys Med Biol 2006;51:3593–602 doi:10.1088/0031-9155/51/14/021 pmid:16825751
    CrossRefPubMedWeb of Science
  16. 16.↵
    1. Choi YS,
    2. Lee HJ,
    3. Ahn SS, et al
    . Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient. Eur Radiol 2017;27:1344–51 doi:10.1007/s00330-016-4484-2 pmid:27436023
    CrossRefPubMed
  17. 17.↵
    1. Appin CL,
    2. Gao J,
    3. Chisolm C, et al
    . Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics. Brain Pathol 2013;23:454–61 doi:10.1111/bpa.12018 pmid:23289977
    CrossRefPubMed
  18. 18.↵
    Vasari MRI Visual Feature Guide. The Cancer Imaging Archive (TCIA) Web site. https://wiki.cancerimagingarchive.net/dis-play/Public/VASARI+Research+Project. . Published March 25, 2015Accessed December 12, 2015.
  19. 19.↵
    1. Wen PY,
    2. Macdonald DR,
    3. Reardon DA, et al
    . Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology working group. J Clin Oncol 2010;28:1963–72 doi:10.1200/JCO.2009.26.3541 pmid:20231676
    Abstract/FREE Full Text
  20. 20.↵
    1. Contal C,
    2. O'Quigley J
    . An application of changepoint methods in studying the effect of age on survival in breast cancer. Computational Statistics & Data Analysis 1999;30:253–70
    CrossRef
  21. 21.↵
    1. Pencina MJ,
    2. D' Agostino RB,
    3. D' Agostino RB, et al
    . Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157–72
    CrossRefPubMedWeb of Science
  22. 22.↵
    1. Jain R,
    2. Poisson LM,
    3. Gutman D, et al
    . Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Radiology 2014;272:484–93 doi:10.1148/radiol.14131691 pmid:24646147
    CrossRefPubMed
  23. 23.↵
    1. Ishwaran H,
    2. Kogalur UB,
    3. Blackstone EH, et al
    . Random survival forests. The Annals of Applied Statistics 2008;2:841–60 doi:10.1214/08-AOAS169
    CrossRefWeb of Science
  24. 24.↵
    1. Roberts C,
    2. Issa B,
    3. Stone A, et al
    . Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging 2006;23:554–63 doi:10.1002/jmri.20529 pmid:16506143
    CrossRefPubMedWeb of Science
  25. 25.↵
    1. Ryoo I,
    2. Choi SH,
    3. Kim JH, et al
    . Cerebral blood volume calculated by dynamic susceptibility contrast-enhanced perfusion MR imaging: preliminary correlation study with glioblastoma genetic profiles. PLoS One 2013;8:e71704 doi:10.1371/journal.pone.0071704 pmid:23977117
    CrossRefPubMed
  26. 26.↵
    1. Ahn SS,
    2. Shin NY,
    3. Chang JH, et al
    . Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging. J Neurosurg 2014;121:367–73 doi:10.3171/2014.5.JNS132279 pmid:24949678
    CrossRefPubMed
  27. 27.↵
    1. Mills SJ,
    2. Patankar TA,
    3. Haroon HA, et al
    . Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006;27:853–58 pmid:16611778
    Abstract/FREE Full Text
  28. 28.↵
    1. Bammer R
    . MR and CT Perfusion and Pharmacokinetic Imaging: Clinical Applications and Theoretical Principles: Lippincott Williams and Wilkins; 2016
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 38 (8)
American Journal of Neuroradiology
Vol. 38, Issue 8
1 Aug 2017
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated MGMT Promoter
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Y.S. Choi, S.S. Ahn, H.-J. Lee, J.H. Chang, S.-G. Kang, E.H. Kim, S.H. Kim, S.-K. Lee
The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated MGMT Promoter
American Journal of Neuroradiology Aug 2017, 38 (8) 1528-1535; DOI: 10.3174/ajnr.A5265

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated MGMT Promoter
Y.S. Choi, S.S. Ahn, H.-J. Lee, J.H. Chang, S.-G. Kang, E.H. Kim, S.H. Kim, S.-K. Lee
American Journal of Neuroradiology Aug 2017, 38 (8) 1528-1535; DOI: 10.3174/ajnr.A5265
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Dynamic Contrast-Enhanced MRI in Patients with Brain Metastases Undergoing Laser Interstitial Thermal Therapy: A Pilot Study
  • Clinically Relevant Imaging Features for MGMT Promoter Methylation in Multiple Glioblastoma Studies: A Systematic Review and Meta-Analysis
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Diagnostic Neuroradiology of Monoclonal Antibodies
  • NCCT vs. MRI for Brain Atrophy in Acute Stroke
  • Clinical Outcomes After Chiari I Decompression
Show more Adult Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire